Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

View the 50 largest pharmaceutical companies in the world listings here

Teva Pharmaceutical Industries in the Drug Discovery & Development Pharma 50

Teva Pharmaceutical Industries

Rank: 26

2021 Rank: 19

Tel Aviv, Israel
www.tevapharm.com

2021 Revenues ($USD) : $15,878,000,000
2021 R&D spend : $618,000,000
2021 Number of Employees : 37,037
Fiscal Year End : 12/31/2021
Leader : CEO Kåre Schultz

Israel-based Teva Pharmaceuticals had $15.9 billion in sales in 2021 but faced some headwinds related to COVID-19. Specializing in generics, Teva was founded in 1935 as Teva Middle East Pharmaceutical & Chemical Works Co. Ltd. in Jerusalem, Israel. Key products in its current portfolio include the Huntington's disease treatment Austedo (deutetrabenazine) and migraine treatment Ajovy (fremanezumab-vfrm). —BB

Teva Pharma

[Teva Pharma image courtesy of Wikipedia]

Tell Us What You Think! Cancel reply

You must be logged in to post a comment.

Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE